Metabolic SyndromeEXMET-BW&YNCT06523790
The Impact of Exercise Methods on Human Body Functions and Metabolism
A study testing Yoga and Brisk walking in people with Metabolic Syndrome, run by Zhoukou Normal University at 1 site in China.
Trial summary
The objective of this study is to compare the effects of 8 months of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women. Participants will be randomly assigned to either a yoga group or a walking group. Read more about this study
- Who is it for?
- Ages 18 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Metabolic Syndrome
- What is being tested?
- Yoga and Brisk walking
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteChina
- Study dates
- 3 Jan 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Female participants aged 18-65 years； Willing and able to participate in an 8-month exercise program； Generally healthy with no contraindications to physical activity； Ability to provide informed consent
Who cannot join
- Current participation in a structured exercise program； Known cardiovascular, respiratory, or metabolic disorders that contraindicate exercise； Pregnancy or planning to become pregnant during the study period； Use of medications affecting metabolism or physical activity levels； Any other condition that, in the opinion of the investigators, would make participation unsafe or not feasible
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Zhou Kou Normal University
Zhoukou, Henan
Jin Li
About this study
Official title: Comparative Study on the Effects of Brisk Walking and Yoga on Glucose and Lipid Metabolism and Neurocognitive Function in Adults: A Randomized Controlled Trial
The objective of this study is to compare the effects of 8 months of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women. Participants will be randomly assigned to either a yoga group or a walking group. The yoga group will undergo 90-minute sessions, 3 times per week, while the walking group will engage in one-hour sessions, 6 times per week. Physical and metabolic markers will be measured at baseline and after 8 months of intervention.
Read the detailed description
This randomized controlled trial aims to investigate the differential impacts of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women over an 8-month period. The study will recruit women aged 18-65 years, who will be randomly assigned to either a yoga group or a walking group.
Yoga Group: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week.
Walking Group: Participants in the walking group will engage in one-hour fast-paced walking sessions, 6 times per week.
Outcome Measures: Physical and metabolic markers will be assessed at baseline and after 8 months of exercise intervention. The primary outcomes will include changes in body weight, BMI, visceral fat, and basal metabolism. Metabolic biomarkers such as serum leptin, glucose, total cholesterol (TC), apolipoprotein A (APOA), and apolipoprotein B (APOB) will also be measured.
Participants will be monitored for adherence to the exercise protocol and any adverse events throughout the study. Data will be collected during the intervention, and analyzed to determine the differential effects of yoga and walking on the measured outcomes.
The study aims to provide insights into the relative benefits of yoga and walking exercise regimens on women's health, particularly in terms of body composition and metabolic health, thereby informing future exercise recommendations and health interventions.
- Conditions
- Metabolic Syndrome
- Being tested
- Yoga, Brisk walking
- Keywords
- Yoga, Walking, Exercise, Body Composition, Metabolic Health
- Medical subject headings
- Metabolic Syndrome, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
YogaBehavioural
Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation.
Brisk walkingBehavioural
Participants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss.
| Study group | Role | What they receive |
|---|---|---|
| Yoga Group | Experimental | Participants in this group will undergo 90-minute yoga sessions, 3 times per week, for 8 months. The yoga intervention includes a combination of asanas (postures), pranayama (breathing exercises), and meditation designed to improve flexibility, strength, and mental well-being. Receives: Behavioral: Yoga |
| Walking Group | Experimental | Participants in this group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking intervention is designed to improve cardiovascular fitness, endurance, and support weight loss. Receives: Behavioral: Brisk walking |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Body Weight
Measurement of body weight changes in kilograms from baseline to 8 months.
Measured: Baseline, 8 months
Change in Body Mass Index (BMI)
Measurement of BMI changes calculated as weight in kilograms divided by height in meters squared from baseline to 8 months.
Measured: Baseline, 8 months
Secondary outcomes (3)
Change in Serum Leptin Levels
Measurement of serum leptin levels in ng/mL from baseline to 8 months.
Measured: Baseline, 8 months
Change in Fasting Blood Glucose Levels
Measurement of fasting blood glucose levels in mg/dL from baseline to 8 months.
Measured: Baseline, 8 months
Change in Total Cholesterol (TC) Levels
Measurement of total cholesterol levels in mg/dL from baseline to 8 months.
Measured: Baseline, 8 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2024
- Study start3 Jan 2024
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 84 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Zhoukou Normal University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jin Li, Zhoukou Normal University
- Investigators
- xiaomeng liu, Principal investigator, Zhoukou Normal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06523790
- Sponsor's protocol ID
- ZhoukouNU-001
- Acronym
- EXMET-BW&Y
- Status last verified
- Jul 2024
- First submitted
- 22 Jul 2024
- Last updated
- 26 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data will not be shared due to concerns about participant privacy and the sensitivity of the health data collected.
Study at a glance
From the registry record, last updated by the sponsor on 26 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study on the Effects of Brisk Walking and Yoga on Glucose and Lipid Metabolism and Neurocognitive Function in Adults: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06523790
- Acronym / sponsor ID
- EXMET-BW&Y / ZhoukouNU-001
- Conditions
- Metabolic Syndrome
- Keywords
- Yoga, Walking, Exercise, Body Composition, Metabolic Health
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 84 participants (estimated)
- Lead sponsor
- Zhoukou Normal UniversityUniversity, hospital or other
- Study start
- 3 Jan 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 26 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to compare the effects of 8 months of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women. Participants will be randomly assigned to either a yoga group or a walking group. The yoga group will undergo 90-minute sessions, 3 times per week, while the walking group will engage in one-hour sessions, 6 times per week. Physical and metabolic markers will be measured at baseline and after 8 months of intervention.
Detailed description
This randomized controlled trial aims to investigate the differential impacts of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women over an 8-month period. The study will recruit women aged 18-65 years, who will be randomly assigned to either a yoga group or a walking group.
Yoga Group: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week.
Walking Group: Participants in the walking group will engage in one-hour fast-paced walking sessions, 6 times per week.
Outcome Measures: Physical and metabolic markers will be assessed at baseline and after 8 months of exercise intervention. The primary outcomes will include changes in body weight, BMI, visceral fat, and basal metabolism. Metabolic biomarkers such as serum leptin, glucose, total cholesterol (TC), apolipoprotein A (APOA), and apolipoprotein B (APOB) will also be measured.
Participants will be monitored for adherence to the exercise protocol and any adverse events throughout the study. Data will be collected during the intervention, and analyzed to determine the differential effects of yoga and walking on the measured outcomes.
The study aims to provide insights into the relative benefits of yoga and walking exercise regimens on women's health, particularly in terms of body composition and metabolic health, thereby informing future exercise recommendations and health interventions.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Yoga Group | Experimental | Behavioral: YogaParticipants in this group will undergo 90-minute yoga sessions, 3 times per week, for 8 months. The yoga intervention includes a combination of asanas (postures), pranayama (breathing exercises), and meditation designed to improve flexibility, strength, and mental well-being. |
| Walking Group | Experimental | Behavioral: Brisk walkingParticipants in this group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking intervention is designed to improve cardiovascular fitness, endurance, and support weight loss. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Female participants aged 18-65 years； Willing and able to participate in an 8-month exercise program； Generally healthy with no contraindications to physical activity； Ability to provide informed consent
Key exclusion criteria (1 listed)
- Current participation in a structured exercise program； Known cardiovascular, respiratory, or metabolic disorders that contraindicate exercise； Pregnancy or planning to become pregnant during the study period； Use of medications affecting metabolism or physical activity levels； Any other condition that, in the opinion of the investigators, would make participation unsafe or not feasible
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| YogaParticipants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation. | Behavioural | Yoga Group |
| Brisk walkingParticipants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss. | Behavioural | Walking Group |
Primary outcome
Change in Body Weight
Time frame: Baseline, 8 months
Measurement of body weight changes in kilograms from baseline to 8 months.
Change in Body Mass Index (BMI)
Time frame: Baseline, 8 months
Measurement of BMI changes calculated as weight in kilograms divided by height in meters squared from baseline to 8 months.
3 secondary outcomes
Change in Serum Leptin Levels
Time frame: Baseline, 8 months
Change in Fasting Blood Glucose Levels
Time frame: Baseline, 8 months
Change in Total Cholesterol (TC) Levels
Time frame: Baseline, 8 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jul 2024.
- Individual participant dataSharing planned: No. The data will not be shared due to concerns about participant privacy and the sensitivity of the health data collected.
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
xiaomeng liu principal investigator
Zhoukou Normal University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Yoga and Brisk walking in people with Metabolic Syndrome, run by Zhoukou Normal University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact jin li ((86)18438175639, lijin0213@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Body Weight (time frame: Baseline, 8 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2024.